Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 44 Records) |
| Query Trace: Disease and ADA[original query] |
|---|
| Transferrin Level Before Treatment and Genetic Polymorphism in HFE Gene as Predictive Markers for Response to Adalimumab in Crohn's Disease Patients. Biochemical genetics 2016 Aug 54 (4): 476-486. Repnik Katja, Koder Silvo, Skok Pavel, Ferkolj Ivan, Potocnik Ur |
| Polymorphisms in STAT4, PTPN2, PSORS1C1 and TRAF3IP2 Genes Are Associated with the Response to TNF Inhibitors in Patients with Rheumatoid Arthritis. PloS one 2017 12 (1): e0169956. Conigliaro Paola, Ciccacci Cinzia, Politi Cristina, Triggianese Paola, Rufini Sara, Kroegler Barbara, Perricone Carlo, Latini Andrea, Novelli Giuseppe, Borgiani Paola, Perricone Rober |
| A FCGR3A Polymorphism Predicts Anti-drug Antibodies in Chronic Inflammatory Bowel Disease Patients Treated With Anti-TNF. International journal of medical sciences 2018 15 (1): 10-15. Romero-Cara Patricia, Torres-Moreno Daniel, Pedregosa José, Vílchez Juan Antonio, García-Simón María Sergia, Ruiz-Merino Guadalupe, Morán-Sanchez Senador, Conesa-Zamora Pab |
| Genetic markers associated with clinical and radiographic response in adalimumab plus methotrexate- or methotrexate-treated rheumatoid arthritis patients in OPTIMA. Clinical and experimental rheumatology 2019 Apr . Skapenko Alla, Smolen Josef S, Kavanaugh Arthur, Arora Vipin, Kupper Hartmut, Schulze-Koops Hendr |
| Germline DNA Repair Gene Mutations in Young-onset Prostate Cancer Cases in the UK: Evidence for a More Extensive Genetic Panel. European urology 2019 Feb . Leongamornlert Daniel A, Saunders Edward J, Wakerell Sarah, Whitmore Ian, Dadaev Tokhir, Cieza-Borrella Clara, Benafif Sarah, Brook Mark N, Donovan Jenny L, Hamdy Freddie C, Neal David E, Muir Kenneth, Govindasami Koveela, Conti David V, Kote-Jarai Zsofia, Eeles Rosalind |
| Genetic mutations and immunological features of severe combined immunodeficiency patients in Iran. Immunology letters 2019 Oct . Shahbazi Zahra, Yazdani Reza, Shahkarami Sepideh, Shahbazi Shirin, Hamid Mohammad, Sadeghi-Shabestari Mahnaz, Momen Tooba, Aleyasin Soheila, Esmaeilzadeh Hossein, Darougar Sepideh, Delavari Sama, Mahdaviani Seyed Alireza, Ahanchian Hamid, Behmanesh Fatemeh, Kiaee Fatemeh, Chavoshzade Zahra, Shariat Mansoureh, Keramatipour Mohammad, Rezaei Nima, Abolhassani Hassan, Parvaneh Nima, Mahdian Reza, Aghamohammadi Asgh |
| HLADQA1*05 genotype predicts anti-drug antibody formation and loss of response during infliximab therapy for inflammatory bowel disease. Alimentary pharmacology & therapeutics 2019 Oct . Wilson Aze, Peel Celeste, Wang Qian, Pananos Athanasios Demetri, Kim Richard |
| Genetic variants in FADS1 and ELOVL2 increase level of arachidonic acid and the risk of Alzheimer's disease in the Tunisian population. Prostaglandins, leukotrienes, and essential fatty acids 2020 Jul 160 102159. Hammouda Souha, Ghzaiel Imen, Khamlaoui Wided, Hammami Sonia, Mhenni Samia Younes, Samet Slim, Hammami Mohamed, Zarrouk Ami |
| Genetic Sequencing of Pediatric Patients Identifies Mutations in Monogenic Inflammatory Bowel Disease Genes that Translate to Distinct Clinical Phenotypes. Clinical and translational gastroenterology 2020 Feb 11 (2): e00129. Ashton James J, Mossotto Enrico, Stafford Imogen S, Haggarty Rachel, Coelho Tracy A F, Batra Akshay, Afzal Nadeem A, Mort Matthew, Bunyan David, Beattie Robert Mark, Ennis Sar |
Clinicogenomic factors of biotherapy immunogenicity in autoimmune disease: A prospective multicohort study of the ABIRISK consortium.
PLoS medicine 2020 10 17 (10): e1003348. Hässler Signe, Bachelet Delphine, Duhaze Julianne, Szely Natacha, Gleizes Aude, Hacein-Bey Abina Salima, Aktas Orhan, Auer Michael, Avouac Jerôme, Birchler Mary, Bouhnik Yoram, Brocq Olivier, Buck-Martin Dorothea, Cadiot Guillaume, Carbonnel Franck, Chowers Yehuda, Comabella Manuel, Derfuss Tobias, De Vries Niek, Donnellan Naoimh, Doukani Abiba, Guger Michael, Hartung Hans-Peter, Kubala Havrdova Eva, Hemmer Bernhard, Huizinga Tom, Ingenhoven Kathleen, Hyldgaard-Jensen Poul Erik, Jury Elizabeth C, Khalil Michael, Kieseier Bernd, Laurén Anna, Lindberg Raija, Loercher Amy, Maggi Enrico, Manson Jessica, Mauri Claudia, Mohand Oumoussa Badreddine, Montalban Xavier, Nachury Maria, Nytrova Petra, Richez Christophe, Ryner Malin, Sellebjerg Finn, Sievers Claudia, Sikkema Dan, Soubrier Martin, Tourdot Sophie, Trang Caroline, Vultaggio Alessandra, Warnke Clemens, Spindeldreher Sebastian, Dönnes Pierre, Hickling Timothy P, Hincelin Mery Agnès, Allez Matthieu, Deisenhammer Florian, Fogdell-Hahn Anna, Mariette Xavier, Pallardy Marc, Broët Philippe, |
| A Single Nucleotide ADA Genetic Variant Is Associated to Central Inflammation and Clinical Presentation in MS: Implications for Cladribine Treatment. Genes 2020 10 11 (10): . Stampanoni Bassi Mario, Buttari Fabio, Simonelli Ilaria, Gilio Luana, Furlan Roberto, Finardi Annamaria, Marfia Girolama Alessandra, Visconti Andrea, Paolillo Andrea, Storto Marianna, Gambardella Stefano, Ferese Rosangela, Salvetti Marco, Uccelli Antonio, Matarese Giuseppe, Centonze Diego, De Vito Frances |
| Adenosine Deaminase Gene Polymorphism and Baseline Serum Level of Adenosine Deaminase as a Biomarker of Response to Methotrexate in Rheumatoid Arthritis. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 2020 Oct . Gangadharan Harikrishnan, Singh Ankita, Majumder Sanjukta, Aggarwal Ami |
| Association of single nucleotide polymorphism (rs741301) of the ELMO1 gene with diabetic kidney disease in Polish patients with type 2 diabetes: a pilot study. Endokrynologia Polska 2020 Jan . Kwiendacz Hanna, Nabrdalik Katarzyna, Adamczyk Piotr, Moczulski Dariusz, Moczulska Hanna, Trautsolt Wanda, Górczy?ska-Kosiorz Sylwia, Grzeszczak W?adys?aw, Gumprecht Janu |
| A Novel LC-MS/MS-Based Method for the Diagnosis of ADA2 Deficiency from Dried Plasma Spot. Molecules (Basel, Switzerland) 2021 9 26 (18): . Cafaro Alessia, Pigliasco Federica, Barco Sebastiano, Penco Federica, Schena Francesca, Caorsi Roberta, Volpi Stefano, Tripodi Gino, Gattorno Marco, Cangemi Giulia |
| Anti-Drug Antibodies in Patients with Inflammatory Bowel Diseases Treated with Biosimilar Infliximab: A Prospective Cohort Study. Journal of clinical medicine 2021 7 10 (12): . P?kala Anna, Filip Rafa?, Aebisher Dav |
| Pharmacogenetic variants of infliximab response in young patients with inflammatory bowel disease. Clinical and translational science 2021 Jun . Curci Debora, Lucafò Marianna, Cifù Adriana, Fabris Martina, Bramuzzo Matteo, Martelossi Stefano, Franca Raffaella, Decorti Giuliana, Stocco Gabrie |
| Omics data integration identifies ELOVL7 and MMD gene regions as novel loci for adalimumab response in patients with Crohn's disease. Scientific reports 2021 Mar 11 (1): 5449. Gorenjak Mario, Zupin Mateja, Jezernik Gregor, Skok Pavel, Poto?nik Ur |
| Identification of Influential Variants in Significant Aggregate Rare Variant Tests. Human heredity 2021 2 1-13. Blumhagen Rachel Z, Schwartz David A, Langefeld Carl D, Fingerlin Tasha |
| Vitamin D-Related Genetics as Predictive Biomarker of Clinical Remission in Adalimumab-Treated Patients Affected by Crohn's Disease: A Pilot Study. Pharmaceuticals (Basel, Switzerland) 2021 12 14 (12): . Cusato Jessica, Bertani Lorenzo, Antonucci Miriam, Tomasello Cristina, Caviglia Gian Paolo, Dibitetto Simone, Massano Alessandro, Mangia Michela, Mula Jacopo, Ceccarelli Linda, Costa Francesco, Zanzi Federico, Astegiano Marco, Ribaldone Davide Giuseppe, D'Avolio Anton |
| HLA-DQA1*05 Associates with Extensive Ulcerative Colitis at Diagnosis: An Observational Study in Children. Genes 2021 12 12 (12): . Nowak Jan Krzysztof, Glapa-Nowak Aleksandra, Banaszkiewicz Aleksandra, Iwa?czak Barbara, Kwiecie? Jaros?aw, Szaflarska-Pop?awska Anna, Grzybowska-Chlebowczyk Urszula, Osiecki Marcin, Kierku? Jaros?aw, Ho?ubiec Magdalena, Chanaj-Kaczmarek Justyna, Radzikowski Andrzej, Walkowiak Jaros? |
| Establishing the Molecular Diagnoses in a Cohort of 291 Patients With Predominantly Antibody Deficiency by Targeted Next-Generation Sequencing: Experience From a Monocentric Study. Frontiers in immunology 2022 1 12 786516. Rojas-Restrepo Jessica, Caballero-Oteyza Andrés, Huebscher Katrin, Haberstroh Hanna, Fliegauf Manfred, Keller Baerbel, Kobbe Robin, Warnatz Klaus, Ehl Stephan, Proietti Michele, Grimbacher Bo |
| Tumor Necrosis Factor-Alpha (+489 G/A) Polymorphism Can Predict the Response to Adalimumab in Chinese Han Patients With Ankylosing Spondylitis. Cureus 2023 9 15 (7): e42704. Hong-Jin Liang, Xiao-Min Jiang, Feng-Cai Shen, Jian-Hua Peng, Dan-Min Wang, Shu-Xin Huang, Zhi-Duo Hou, Ling L |
| Multiple genetic variants involved in both autoimmunity and autoinflammation detected in Chinese patients with sporadic Meniere's disease: a preliminary study. Frontiers in neurology 2023 6 14 1159658. Jing Zou, Guoping Zhang, Hongbin Li, Zikai Zhao, Qing Zhang, Ilmari Pyykkö, Antti Mäkit |
| Pharmacogenetic Sex-Specific Effects of Methotrexate Response in Patients with Rheumatoid Arthritis. Pharmaceutics 2023 6 15 (6): . Francisco C Ceballos, Eugenio Chamizo-Carmona, Carmen Mata-Martín, Carmen Carrasco-Cubero, Juan J Aznar-Sánchez, Raúl Veroz-González, Sara Rojas-Herrera, Pedro Dorado, Adrián LLere |
| Hypertension, type 2 diabetes, obesity, and p53 mutations negatively correlate with metastatic colorectal cancer patients' survival. Frontiers in medicine 2023 2 10 1091634. Ottaiano Alessandro, Santorsola Mariachiara, Circelli Luisa, Perri Francesco, Cascella Marco, Sabbatino Francesco, Capuozzo Maurizio, Granata Vincenza, Zappavigna Silvia, Lombardi Angela, Scrima Marianna, Petrillo Nadia, Ianniello Monica, Casillo Marika, Gualillo Oreste, Nasti Guglielmo, Caraglia Michele, Savarese Giovan |
| MIF Variant rs755622 Is Associated with Severe Crohn's Disease and Better Response to Anti-TNF Adalimumab Therapy. Genes 2023 2 14 (2): . Jezernik Gregor, Gorenjak Mario, Poto?nik Ur |
| Association between genetic variants and development of antibodies to infliximab: A cross-sectional study in Chinese patients with Crohn's disease. Frontiers in pharmacology 2023 2 14 1096816. Zhu Kouzhu, Ding Xiaoliang, Chen Zhiyao, Xi Qinhua, Pang Xueqin, Chen Weichang, Miao Liy |
| HLA-DQA1*05 correlates with increased risk of anti-drug antibody development and reduced response to infliximab in Chinese patients with Crohn's disease. Gastroenterology report 2024 7 12 goae074. Wei Wang, Qi Zhang, Junzhang Zhao, Tao Liu, Jiayin Yao, Xiang Peng, Min Zhi, Min Zha |
| HLA-DQA1*05 Allele Carriage and Anti-TNF Therapy Persistence in Inflammatory Bowel Disease. Inflammatory bowel diseases 2024 6 . Jayne Doherty, Anthony W Ryan, Emma Quinn, Judith Conroy, Jackie Dolan, Roisin Corcoran, Fintan O Hara, Garret Cullen, Juliette Sheridan, Yvonne Bailey, Cara Dunne, Karen Hartery, Deirdre McNamara, Glen A Doherty, David Keva |
| Carriage of the HLA-DQA1?05 haplotype is associated with a higher risk of infratherapeutic drug concentration and higher immunogenicity in patients undergoing treatment with anti-TNF for inflammatory bowel disease. Therapeutic advances in gastroenterology 2024 10 17 17562848241278145. Pilar Navajas Hernández, Samer Mouhtar El Halabi, Ana Caridad González Parra, Teresa Valdés Delgado, Belén Maldonado Pérez, Luisa Castro Laria, Cloé Charpentier, Federico Argüelles-Ari |
- Page last reviewed:Feb 1, 2024
- Content source: